Documents
Application Sponsors
NDA 020222 | PHARMACIA UPJOHN | |
Marketing Status
Application Products
001 | TABLET;ORAL | 1GM | 1 | COLESTID | COLESTIPOL HYDROCHLORIDE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 1994-07-19 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 2002-04-12 | PRIORITY |
LABELING; Labeling | SUPPL | 5 | AP | 2014-05-22 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2017-05-25 | STANDARD |
Submissions Property Types
SUPPL | 2 | Null | 0 |
SUPPL | 5 | Null | 7 |
SUPPL | 6 | Null | 7 |
TE Codes
CDER Filings
PFIZER
cder:Array
(
[0] => Array
(
[ApplNo] => 20222
[companyName] => PFIZER
[docInserts] => ["",""]
[products] => [{"drugName":"COLESTID","activeIngredients":"COLESTIPOL HYDROCHLORIDE","strength":"1GM","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"05\/25\/2017","submission":"SUPPL-6","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/020222Orig1s006lbl.pdf\"}]","notes":""},{"actionDate":"05\/25\/2017","submission":"SUPPL-6","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/020222Orig1s006lbl.pdf\"}]","notes":""},{"actionDate":"05\/22\/2014","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/017563s023,020222s005lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"COLESTID","submission":"COLESTIPOL HYDROCHLORIDE","actionType":"1GM","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2017-05-25
)
)